Diffuse Colour Discrimination as Marker of Afferent Visual System Dysfunction in Amyotrophic Lateral Sclerosis
Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hyp...
Saved in:
Published in | Neuro-ophthalmology (Amsterdam : Aeolus Press. 1980) Vol. 41; no. 6; pp. 310 - 314 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
02.11.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS (n = 25, aged 50-80 years) and control (n = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% (n = 18) of ALS subjects had colour vision below the 50th percentile, 52% (n = 13) had colour vision below the 25th percentile, 24% (n = 6) had colour vision below the 10th percentile, and 8% (n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity. |
---|---|
AbstractList | Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS (n = 25, aged 50-80 years) and control (n = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% (n = 18) of ALS subjects had colour vision below the 50th percentile, 52% (n = 13) had colour vision below the 25th percentile, 24% (n = 6) had colour vision below the 10th percentile, and 8% (n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity.Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS (n = 25, aged 50-80 years) and control (n = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% (n = 18) of ALS subjects had colour vision below the 50th percentile, 52% (n = 13) had colour vision below the 25th percentile, 24% (n = 6) had colour vision below the 10th percentile, and 8% (n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity. Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS ( n = 25, aged 50–80 years) and control ( n = 21, aged 46–89 years) subjects with corrected near visual acuity of at least 20/40 using the L’Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% ( n = 18) of ALS subjects had colour vision below the 50th percentile, 52% ( n = 13) had colour vision below the 25th percentile, 24% ( n = 6) had colour vision below the 10th percentile, and 8% ( n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity. Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS ( = 25, aged 50-80 years) and control ( = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% ( = 18) of ALS subjects had colour vision below the 50th percentile, 52% ( = 13) had colour vision below the 25th percentile, 24% ( = 6) had colour vision below the 10th percentile, and 8% ( = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity. Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS (n = 25, aged 50-80 years) and control (n = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% (n = 18) of ALS subjects had colour vision below the 50th percentile, 52% (n = 13) had colour vision below the 25th percentile, 24% (n = 6) had colour vision below the 10th percentile, and 8% (n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity. |
Author | Moss, Heather E. Boven, Lindsay Jiang, Qin Li |
Author_xml | – sequence: 1 givenname: Lindsay surname: Boven fullname: Boven, Lindsay organization: Department of Ophthalmology and Visual Sciences, University of Illinois College of Medicine – sequence: 2 givenname: Qin Li surname: Jiang fullname: Jiang, Qin Li organization: Department of Neurology and Rehabilitation, University of Illinois at Chicago – sequence: 3 givenname: Heather E. surname: Moss fullname: Moss, Heather E. email: hemoss@stanford.edu organization: Departments of Ophthalmology and Visual Sciences and Neurology and Rehabilitation, University of Illinois at Chicago |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29344070$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU1v1DAYhC1URLeFnwDykUu2tmPnQ0iI1S60lRZx4EPcLMd5TQ2JvbUTUP59ne4ugh7g5IOfmbFnztCJ8w4Qek7JkpKKXBBaiIqScskILZc0ZwUV-SO0oCXnmSDF1xO0mJlshk7RWYzfCSFcCPYEnbI655yUZIHcxhozRsBr3_kx4I2NOtjeOjVY77CK-L0KPyBgb_DKGAjgBvzFxlF1-OMUB-jxZopmdPqetw6v-skPwe9urMZbNUCYSd1B8NHGp-ixUV2EZ4fzHH1-9_bT-irbfri8Xq-2meaMDhknbWGoIrQpa1qavGm4ygtD2gaghVowqHRNG85FKWpVtA2lilUgGFEVE8zk5-j13nc3Nj20Or06vUPu0tdUmKRXVv594-yN_OZ_SlEWnBQsGbw8GAR_O0IcZJ-aga5TDvwYJa2rWtS8KvOEvvgz63fIseQEvNoDOnUQAxip7XDfb4q2naREzpPK46RynlQeJk1q8UB9DPif7s1eZ53xoVe_fOhaOaip88EE5bSNMv-3xR3QO7oH |
CitedBy_id | crossref_primary_10_1080_2326263X_2019_1697163 crossref_primary_10_24075_brsmu_2021_043 crossref_primary_10_2147_EB_S299423 crossref_primary_10_1080_17483107_2020_1754929 crossref_primary_10_1016_j_neurol_2022_11_010 crossref_primary_10_1186_s40478_024_01858_0 crossref_primary_10_1002_mus_26387 crossref_primary_10_1111_ene_16475 |
Cites_doi | 10.4103/0301-4738.99842 10.3109/21678421.2014.951941 10.1038/srep29187 10.1371/journal.pone.0168714 10.1177/1352458513517591 10.1016/j.jns.2011.10.016 10.1016/S0892-0362(97)00046-9 10.1016/S0022-510X(99)00204-X 10.1097/00006324-199310000-00005 10.1016/j.ajo.2015.06.015 10.1212/01.WNL.0000154521.40686.63 10.1016/j.jns.2014.07.022 |
ContentType | Journal Article |
Copyright | 2017 Taylor & Francis 2017 2017 Taylor & Francis 2017 Taylor & Francis |
Copyright_xml | – notice: 2017 Taylor & Francis 2017 – notice: 2017 Taylor & Francis 2017 Taylor & Francis |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.1080/01658107.2017.1326153 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | L. BOVEN ET AL |
EISSN | 1744-506X |
EndPage | 314 |
ExternalDocumentID | PMC5764062 29344070 10_1080_01658107_2017_1326153 1326153 |
Genre | Article Journal Article |
GrantInformation_xml | – fundername: National Eye Institute grantid: K12 EY02147; K23 EY024345 funderid: 10.13039/100000053 – fundername: NEI NIH HHS grantid: K23 EY024345 – fundername: NEI NIH HHS grantid: K12 EY021475 – fundername: ; ; grantid: K12 EY02147; K23 EY024345 |
GroupedDBID | --- 00X 03L 0R~ 123 29N 4.4 53G 5RE AALUX AAMIU AAPUL AAQRR ABBKH ABDBF ABEIZ ABJNI ABLIJ ABLJU ABLKL ABUPF ABWVI ABXYU ACENM ACGEJ ACGFS ACIEZ ACUHS ADBBV ADCVX ADRBQ ADXPE ADYSH AECIN AEOZL AFKVX AFRVT AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALMA_UNASSIGNED_HOLDINGS ALQZU ALYBC AMDAE AMPGV AOIJS BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EAP EBC EBD EBS EJD EMK EPL ESX F5P H13 HYE HZ~ KRBQP KSSTO KWAYT KYCEM M4Z O9- OK1 P2P RNANH RPM RVRKI TBQAZ TDBHL TERGH TFDNU TFL TFW TUROJ TUS UEQFS V1S ~1N AAGDL AAYXX CITATION .GJ 5VS AALIY AAORF AAPXX ABWCV ABZEW ACKZS ACOPL ACYZI ADFOM ADFZZ AEIIZ AFLEI AJVHN AWYRJ BRMBE CAG COF CYYVM CZDIS DRXRE DWTOO JENTW LJTGL M44 NPM NUSFT QQXMO TASJS ZGI 7X8 5PM |
ID | FETCH-LOGICAL-c421t-40d6f1a01b7917f3bb4a36f0dbeede952e8c91b445759a6db11a28e520a8252f3 |
ISSN | 0165-8107 |
IngestDate | Thu Aug 21 17:50:30 EDT 2025 Fri Jul 11 12:43:19 EDT 2025 Mon Jul 21 05:52:06 EDT 2025 Tue Jul 01 03:36:41 EDT 2025 Thu Apr 24 23:10:05 EDT 2025 Tue May 20 10:47:22 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | desaturated L’Anthony D-15 Amyotrophic lateral sclerosis retinal disease colour vision |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c421t-40d6f1a01b7917f3bb4a36f0dbeede952e8c91b445759a6db11a28e520a8252f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 The current affiliation of Heather E. Moss is Departments of Ophthalmology & Neurology and Neurosciences, Stanford University, Palo Alto, California, USA. |
PMID | 29344070 |
PQID | 1989594873 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmed_primary_29344070 informaworld_taylorfrancis_310_1080_01658107_2017_1326153 crossref_citationtrail_10_1080_01658107_2017_1326153 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5764062 proquest_miscellaneous_1989594873 crossref_primary_10_1080_01658107_2017_1326153 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-11-02 |
PublicationDateYYYYMMDD | 2017-11-02 |
PublicationDate_xml | – month: 11 year: 2017 text: 2017-11-02 day: 02 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Neuro-ophthalmology (Amsterdam : Aeolus Press. 1980) |
PublicationTitleAlternate | Neuroophthalmology |
PublicationYear | 2017 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | CIT0010 CIT0001 CIT0012 CIT0011 Diederich NJ (CIT0013) 1998; 21 CIT0003 CIT0014 CIT0002 CIT0005 CIT0016 CIT0004 CIT0015 CIT0006 CIT0017 Vingrys AJ, King-Smith PE (CIT0008) 1988; 29 22192877 - J Neurol Sci. 2012 Mar 15;314(1-2):97-101 3257208 - Invest Ophthalmol Vis Sci. 1988 Jan;29(1):50-63 26877563 - Trans Am Ophthalmol Soc. 2015 ;113:T12 8247482 - Optom Vis Sci. 1993 Oct;70(10):809-13 24399824 - Mult Scler. 2014 Aug;20(9):1207-16 23514643 - Indian J Ophthalmol. 2013 Mar;61(3):100-3 27383525 - Sci Rep. 2016 Jul 07;6:29187 26116263 - Am J Ophthalmol. 2015 Sep;160(3):547-552.e1 28033389 - PLoS One. 2016 Dec 29;11(12 ):e0168714 9789709 - Clin Neuropharmacol. 1998 Sep-Oct;21(5):289-95 10620653 - J Neurol Sci. 2000 Jan 1;172(1):7-11 15781814 - Neurology. 2005 Mar 22;64(6):992-5 9392781 - Neurotoxicol Teratol. 1997 Nov-Dec;19(6):455-65 25319030 - Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):569-80 25086858 - J Neurol Sci. 2014 Oct 15;345(1-2):118-24 |
References_xml | – ident: CIT0014 doi: 10.4103/0301-4738.99842 – volume: 29 start-page: 50 year: 1988 ident: CIT0008 publication-title: Invest Ophthalmol Vis Sci – ident: CIT0001 doi: 10.3109/21678421.2014.951941 – volume: 21 start-page: 289 year: 1998 ident: CIT0013 publication-title: Clin Neuropharmacol – ident: CIT0003 doi: 10.1038/srep29187 – ident: CIT0005 doi: 10.1371/journal.pone.0168714 – ident: CIT0016 doi: 10.1177/1352458513517591 – ident: CIT0004 doi: 10.1016/j.jns.2011.10.016 – ident: CIT0006 doi: 10.1016/S0892-0362(97)00046-9 – ident: CIT0012 doi: 10.1016/S0022-510X(99)00204-X – ident: CIT0011 doi: 10.1097/00006324-199310000-00005 – ident: CIT0002 – ident: CIT0017 doi: 10.1016/j.ajo.2015.06.015 – ident: CIT0015 doi: 10.1212/01.WNL.0000154521.40686.63 – ident: CIT0010 doi: 10.1016/j.jns.2014.07.022 – reference: 15781814 - Neurology. 2005 Mar 22;64(6):992-5 – reference: 8247482 - Optom Vis Sci. 1993 Oct;70(10):809-13 – reference: 26116263 - Am J Ophthalmol. 2015 Sep;160(3):547-552.e1 – reference: 28033389 - PLoS One. 2016 Dec 29;11(12 ):e0168714 – reference: 25086858 - J Neurol Sci. 2014 Oct 15;345(1-2):118-24 – reference: 27383525 - Sci Rep. 2016 Jul 07;6:29187 – reference: 22192877 - J Neurol Sci. 2012 Mar 15;314(1-2):97-101 – reference: 9789709 - Clin Neuropharmacol. 1998 Sep-Oct;21(5):289-95 – reference: 26877563 - Trans Am Ophthalmol Soc. 2015 ;113:T12 – reference: 9392781 - Neurotoxicol Teratol. 1997 Nov-Dec;19(6):455-65 – reference: 10620653 - J Neurol Sci. 2000 Jan 1;172(1):7-11 – reference: 24399824 - Mult Scler. 2014 Aug;20(9):1207-16 – reference: 25319030 - Amyotroph Lateral Scler Frontotemporal Degener. 2014 Dec;15(7-8):569-80 – reference: 3257208 - Invest Ophthalmol Vis Sci. 1988 Jan;29(1):50-63 – reference: 23514643 - Indian J Ophthalmol. 2013 Mar;61(3):100-3 |
SSID | ssj0004552 |
Score | 2.1182485 |
Snippet | Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence... |
SourceID | pubmedcentral proquest pubmed crossref informaworld |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 310 |
SubjectTerms | Amyotrophic lateral sclerosis colour vision desaturated L'Anthony D-15 Original retinal disease |
Title | Diffuse Colour Discrimination as Marker of Afferent Visual System Dysfunction in Amyotrophic Lateral Sclerosis |
URI | https://www.tandfonline.com/doi/abs/10.1080/01658107.2017.1326153 https://www.ncbi.nlm.nih.gov/pubmed/29344070 https://www.proquest.com/docview/1989594873 https://pubmed.ncbi.nlm.nih.gov/PMC5764062 |
Volume | 41 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEBbtFkovpe-mL1ToLThYsvw6pt1dQsluKSQlNyM5MjEk9rJ2Cttf3xlLduw2sNteRLAlWfF8lkajmW8I-cQ9BctmmDl46gYbFJE6UqfSYSmUoCDwKMNA4YvLYLYUX1f-6mDQb6JLajVJfx2NK_kfqcI1kCtGyf6DZLtO4QL8BvlCCRKG8k4yPs2zbF9h4rktVEcmzdRk6TLpv6smEkc35wBTkwelHv_IK4wYMUzl49ObCle21uNxursp6-vyapOn47nE4GTkCtlqWErzqq_HNpweDlSsN3K7MzxOoKtOd8i7sJa7xtIw1fDvK-PlMUG7g9uzO3wuf5oZD60CVc-VJ7cW7O8wnnneAcJmd58ZldUGUFhzBSyBaIIdWDAD34lsqtt2CjbcVxZq_fnUMz6vf83z1jES-sKu0EMvnMC-GrXXw8LWHuZffkvOl_N5sjhbLe6TBxw2FLy163S88k1upm5wbawXsrAfe8hAixlw3B7bqfzpcNvTYBZPyGO79aBTg6On5J4unpGHF9a54jkpLJyogRMdwonKiho40TKjLZyogRM1cKI9ONG8oD04UQsn2sHpBVmeny2-zBybjsNJBWc1fMjrIGPSZSqEPX7mKSWkF2TuWoGepWOf6yiNmRICc77KYK0YkzzSPndlxH2eeS_JSVEW-jWhLHAz7QqheKxEHPnSY8qL4f34XKl1yEZEtK83SS1XPaZM2SaspbS1UklQKomVyohMumZXhqzltgZxX3ZJ3VjJMpPSJvFuafuxFXQCUzKes8lCl_sqQTdEZEEKoc4rI_huOKBdCwHL7IiEA0h0FZDufXinyDcN7bsfBqB98zd3eO5b8ujw7b0jJ_X1Xr8H5blWHxrc_waQUMIx |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diffuse+Colour+Discrimination+as+Marker+of+Afferent+Visual+System+Dysfunction+in+Amyotrophic+Lateral+Sclerosis&rft.jtitle=Neuro-ophthalmology+%28Amsterdam+%3A+Aeolus+Press.+1980%29&rft.au=Boven%2C+Lindsay&rft.au=Jiang%2C+Qin+Li&rft.au=Moss%2C+Heather+E&rft.date=2017-11-02&rft.issn=0165-8107&rft.volume=41&rft.issue=6&rft.spage=310&rft_id=info:doi/10.1080%2F01658107.2017.1326153&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0165-8107&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0165-8107&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0165-8107&client=summon |